INNOVATE CORP. Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31)
INNOVATE CORP. (VATE) reported Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) of $11.30 million for the 12-month period ending 2019-12-31, per its 8-K filed 2020-10-07.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems · last filed 2020-10-07
- INNOVATE CORP. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for the quarter ending 2018-12-31 was -$9.01M, a 150.82% decline year-over-year.
- INNOVATE CORP. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for the quarter ending 2018-09-30 was $24.18M.
- INNOVATE CORP. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for the quarter ending 2018-06-30 was $21.22M, a 535.45% increase year-over-year.
- INNOVATE CORP. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for the quarter ending 2018-03-31 was -$10.60M.
- INNOVATE CORP. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for fiscal 2017 was $7.60M, a 85.30% decline from fiscal 2016.
- INNOVATE CORP. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for fiscal 2016 was $51.70M.
- INNOVATE CORP. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for fiscal 2015 was -$18.74M, a 464.51% decline from fiscal 2014.
- INNOVATE CORP. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for fiscal 2014 was $5.14M.
| Period end | Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) 3 month | Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) 6 month | Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) 9 month | Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) 12 month | Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | $11.30M 8-K · filed 2020-10-07 | $4.10M 10-K · filed 2020-03-16 | |||
| 2018-12-31 | -$9.01M derived: 8-K 12 month − 10-Q 9 month · filed 2020-10-07 | $15.17M derived: sum of 2 quarters · filed 2020-10-07 | $36.40M derived: sum of 3 quarters · filed 2020-10-07 | $25.80M 8-K · filed 2020-10-07 | $38.70M 10-K · filed 2019-03-12 |
| 2018-09-30 | $24.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $45.40M derived: sum of 2 quarters · filed 2018-11-06 | $34.80M 10-Q · filed 2018-11-06 | $52.52M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2018-06-30 | $21.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $10.63M 10-Q · filed 2018-08-08 | $28.35M derived: sum of 3 quarters · filed 2019-03-12 | $24.13M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2018-03-31 | -$10.60M 10-Q · filed 2018-05-10 | $7.12M derived: sum of 2 quarters · filed 2019-03-12 | $2.91M derived: sum of 3 quarters · filed 2019-03-12 | $6.25M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-12-31 | $17.72M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $13.50M derived: sum of 2 quarters · filed 2019-03-12 | $16.84M derived: sum of 3 quarters · filed 2019-03-12 | $7.60M 10-K · filed 2019-03-12 | $7.60M 10-K · filed 2018-03-14 |
| 2017-09-30 | -$4.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$875.00K derived: sum of 2 quarters · filed 2018-11-06 | -$10.12M 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | $3.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$5.90M 10-Q · filed 2018-08-08 | |||
| 2017-03-31 | -$9.24M 10-Q · filed 2018-05-10 | ||||
| 2016-12-31 | $51.70M 10-K · filed 2019-03-12 | $51.69M 10-K · filed 2017-03-09 | |||
| 2015-12-31 | $7.01M derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-14 | -$18.74M 10-K · filed 2018-03-14 | |||
| 2015-09-30 | -$25.75M 10-Q/A · filed 2016-03-15 | ||||
| 2014-12-31 | $5.14M 10-K · filed 2017-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TECHPRECISION CORP (TPCS) | United States | $0.053B | 108.37 |
| Proto Labs Inc (PRLB) | United States | $2.226B | 64.02 |
| Arcosa, Inc. (ACA) | United States | $7.195B | 14.51 |
| VALMONT INDUSTRIES INC (VMI) | United States | $8.988B | 22.19 |